Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Conatus Pharmaceuticals Inc. (CNAT)

5.05 -0.01 (-0.20%)

10/23/2017  11:02am

Open:

5.08

Pre. Close:

5.06

High:

5.10

Low:

4.88

Volume:

84,916

Market Cap:

151.52M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.22 - 5.27

5.27 - 5.32

Low:

4.71 - 4.76

4.76 - 4.81

Close:

4.99 - 5.07

5.07 - 5.15

Technical analysis  (as of: 2017-10-23 10:28:17 AM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 6.65     One year: 7.22

Support:

Support1: 4.90    Support2: 4.08

Resistance:

Resistance1: 5.69    Resistance2: 6.18

Pivot:

5.38

Moving Averages:

MA(5): 5.05     MA(20): 5.41

MA(100): 5.53     MA(250): 4.95

MACD:

MACD(12,26): -0.14     Signal(12,26,9): -0.08

%K %D:

%K(14,3): 5.61     %D(3): 7.79

RSI:

RSI(14): 34.31

52-Week:

High: 9.40  Low: 1.45  Change(%): 143.2

Average Vol(K):

3-Month: 29114  10-Days 29380

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CNAT has closed above bottom band by 7.9%. Bollinger Bands are 8.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 20 Oct 2017 12:00:00 GMT
Conatus Pharmaceuticals Announces Poster Presentation at AASLD Annual Meeting

Wed, 18 Oct 2017 20:03:45 GMT
Conatus Pharmaceuticals (CNAT) Granted Orphan Drug Designation for IDN-7314 ...

Tue, 17 Oct 2017 10:59:00 GMT
Technical Insights on Biotech Stocks -- Conatus Pharma, Immunomedics, INSYS ...

Mon, 23 Oct 2017 14:48:45 GMT
Important Trade and Target Levels To Watch: Merck & Co., Inc. (MRK), Conatus ...

Mon, 23 Oct 2017 14:08:31 GMT
Looking Under the Hood at Shares of Conatus Pharmaceuticals Inc. (NasdaqGM:CNAT)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

30.00

Shares Float (M)

27.09

% Held by Insiders

3.41

% Held by Institutions

40.34

Shares Short (K)

2550

Shares Short Prior Month (K)

2980

Stock Financials

EPS

-0.980

EPS Est. Current Year

-0.530

EPS Est. Next Year

0.700

EPS Est. Next Quarter

-0.150

Forward EPS

0.210

Book Value (p.s.)

1.140

PEG Ratio

-0.25

Profit Margin

-140.57

Operating Margin

-141.34

Return on Assets (ttm)

-24.0

Return on Equity (ttm)

-80.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.027

Sales Per Share

0.594

EBITDA (p.s.)

-0.835

Qtrly Earnings Growth

Operating Cash Flow (M)

18.61

Levered Free Cash Flow (M)

12.19

FoxReading.com

Valuation

P/E

-5.01

P/E Growth Ratio

-0.03

P/BV

4.31

P/S

8.28

P/CF

7.92

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.